ADR Flashcards
related to the pharmacological action of the drug
extension effects
detection: early in clinical development
dose dependent
ADR Type A - Augmented
not related to the pharmacological effect
side effects
ADR Type A - Augmented
oral hypoglycemics
hypoglycemia
extension effects
ADR Type A - Augmented
steroids
immunosuppression
extension effects
ADR Type A - Augmented
cns depressants (benzo/barbiturates)
sedation
extension effects
ADR Type A - Augmented
anticoagulants
bleeding
extension effects
ADR Type A - Augmented
antihypertensives
hypotension
extension effects
ADR Type A - Augmented
opiates
constipation
side effects
ADR Type A - Augmented
nitroglycerin
headache
side effects (vasodilated nerves in head)
ADR Type A - Augmented
ACEI
cough
side effects (bradykinin)
ADR Type A - Augmented
minoxidil
hirsutism
side effects
ADR Type A - Augmented
antihistamine
sedation
side effects (histamine = NT for wakefulness)
ADR Type A - Augmented
statins
rhabdomyolysis/hepatoxicity
side effects
ADR Type A - Augmented
aminoglycosides
nephro/oto/vestibulotoxicity
side effects
ADR Type A - Augmented
not pharmacologically predictable
bizarre
not dose dependent
detection: post-licensing
genetically determined
idiosyncracy
ADR type B- Bizarre
malignant hyperthermia
caused by succinyl choline
DOC: dantrolene
idiosyncracy
ADR type B- Bizarre
hemolytic anemia
caused by G6PD deficiency and the ff
nsaids, sulfa drugs, soya/bean, camphor/menthol
idiosyncracy
ADR type B- Bizarre
stevens-johnson syndrome
caused by sulfa drugs
toxic epidermal necrolysis
idiosyncracy
ADR type B- Bizarre
determined by immune factors
ex asthma, dermatitis, allergic rhinitis, etc
hypersensitivity reactions
ADR type B - Bizarre
IgE mediated hypersensitivity
Type I - anaphylactic/immediate
b-cell mediated
DOC: epinephrine
symptoms: angioedema, urticaria, hives
low BP, bronchoconstriction
food allergy
Type I - anaphylactic/immediate
b-cell (IgE) mediated
hypersensitivity reactions
ADR Type B - Bizarre
penicillin allergy
Type I - anaphylactic/immediate
b-cell (IgE) mediated
hypersensitivity reactions
ADR Type B - Bizarre
nsaids allergy
Type I - anaphylactic/immediate
b-cell (IgE) mediated
hypersensitivity reactions
ADR Type B - Bizarre
IgG mediated cytotoxic hypersensitivity
Type II - Cytotoxic
b-cell (IgG, IgM) mediated
hypersensitivity reactions
ADR Type B - Bizarre
eryhtroblastosis fetalis
hemolytic disease of the newborn
Rh incompatibility (+ & -) blood type
DOC: Rhogam (Rh Ig)
give: 28 weeks pregnant; 72 hrs after birth
Type II - Cytotoxic
b-cell (IgG, IgM) mediated
hypersensitivity reactions
ADR Type B - Bizarre
immune complex-mediated hypersensitivity
Type III - Immune complex-mediated
b-cell mediated
hypersensitivity reactions
ADR Type B - Bizarre
rheumatoid arthritis
Type III - Immune complex-mediated
b-cell mediated
hypersensitivity reactions
ADR Type B - Bizarre
systemic lupus erythematosus
Type III - Immune complex-mediated
b-cell mediated
hypersensitivity reactions
ADR Type B - Bizarre
cell-mediated hypersensitivity
Type IV - Delayed/T cell mediated
after 72 hrs
hypersensitivity reactions
ADR Type B - Bizarre
contact dermatitis
Type IV - Delayed/T cell mediated
after 72 hrs
hypersensitivity reactions
ADR Type B - Bizarre
graft rejection
Type IV - Delayed/T cell mediated
after 72 hrs
hypersensitivity reactions
ADR Type B - Bizarre
mantoux test
Type IV - Delayed/T cell mediated
after 72 hrs
hypersensitivity reactions
ADR Type B - Bizarre
cumulative dose of the drug
ADR Type C - Continuous
dose and time-related
prolonged exposure
takes drug compulsively despite harm and desire to stop
addiction
ADR Type C - Continuous
marijuana
addiction
ADR Type C - Continuous
cocaine
addiction
ADR Type C - Continuous
amphetamines
addiction
ADR Type C - Continuous
LSD
addiction
ADR Type C - Continuous
withdrawal effects w/out drug
dependence
ADR Type C - Continuous
benzodiazepines
dependence
ADR Type C - Continuous
caffeine
physiological dependence - body cant function well
psychological dependence - mind cant function well
dependence
ADR Type C - Continuous
normal dose has less or no effect
tolerance/ tachyphylaxis
ADR Type C - Continuous
nicotine
tolerance/ tachyphylaxis
ADR Type C - Continuous
ability to cause caner/ neoplasm/ malignancy
carcinogenicity
ADR Type D - Delayed
antineoplastic agents
carcinogenicity
ADR Type D - Delayed
hydrocarbons
carcinogenicity
ADR Type D - Delayed
aflatoxin
causes liver cancer
carcinogenicity
ADR Type D - Delayed
benzene
carcinogenicity
ADR Type D - Delayed
PVC
carcinogenicity
ADR Type D - Delayed
asbestos
causes lung cancer
carcinogenicity
ADR Type D - Delayed
ability to cause fetal malformations
teratogenicity
ADR Type D - Delayed
neural tube defect
carbamazepine
valproic acid
teratogenicity
ADR Type D - Delayed
vaginal adenocarcinoma
diethylstilbestrol
teratogenicity
ADR Type D - Delayed
fetal hydantoin syndrome
phenytoin
teratogenicity
ADR Type D - Delayed
phocomelia
thalidomide
teratogenicity
ADR Type D - Delayed
renal agenesis
ACEI/ARBS
teratogenicity
ADR Type D - Delayed
cleft lip, ear/eye defects, mental retardation
isotretinoin (must stop 3 months before pregnancy)
teratogenicity
ADR Type D - Delayed
withdrawal symptoms
ADR Type E - End of use
remedy: taper dose
opiates
irritability
ADR Type E - End of use
rebound insomnia & excitation
benzodiazepine
ADR Type E - End of use
rebound hypertension
clonidine
ADR Type E - End of use
rebound congestion
nasal decongestants
adrenal crisis
steroids
drug-drug interactions
ADR Type F - Failure of efficacy
use of counterfeit
ADR Type F - Failure of efficacy
drug instability
ADR Type F - Failure of efficacy
patient non compliance
ADR Type F - Failure of efficacy
wrong route of administration
ADR Type F - Failure of efficacy
drug resistance
ADR Type F - Failure of efficacy